ECSP19018367A - Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6 - Google Patents

Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6

Info

Publication number
ECSP19018367A
ECSP19018367A ECSENADI201918367A ECDI201918367A ECSP19018367A EC SP19018367 A ECSP19018367 A EC SP19018367A EC SENADI201918367 A ECSENADI201918367 A EC SENADI201918367A EC DI201918367 A ECDI201918367 A EC DI201918367A EC SP19018367 A ECSP19018367 A EC SP19018367A
Authority
EC
Ecuador
Prior art keywords
binding
interleukin
antigen
antibody
human receptor
Prior art date
Application number
ECSENADI201918367A
Other languages
English (en)
Inventor
Yulia Sergeevna Chernykh
Aleksandr Aleksandrovich Moshchenko
Viktoriia Evgenevna Nalobina
Dmitry Valentinovich Morozov
Tatiana Veniaminovna Chernovskaya
Stanislav Rudolfovich Evdokimov
Oleg Igorevich Smotrov
Anna Konstantinovna Vladimirova
Andrei Borisovich Ulitin
Valery Vladimirovich Solovyev
Roman Alekseevich Ivanov
Timofey Aleksandrovich Nemankin
Aleksei Aleksandrovich Aleksandrov
Original Assignee
Biocad Joint Stock Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocad Joint Stock Co filed Critical Biocad Joint Stock Co
Priority to ECSENADI201918367A priority Critical patent/ECSP19018367A/es
Publication of ECSP19018367A publication Critical patent/ECSP19018367A/es

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to medicine. The present invention relates to development of antibodies or fragments thereof capable of specific binding to the human interleukin-6 receptor, which could be used as drugs for treating or diagnosing diseases or alleviating interleukin-6-mediated symptoms. The invention also relates to methods of producing said antibodies and a method of treating human diseases with using said antibodies.
ECSENADI201918367A 2019-03-14 2019-03-14 Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6 ECSP19018367A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSENADI201918367A ECSP19018367A (es) 2019-03-14 2019-03-14 Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSENADI201918367A ECSP19018367A (es) 2019-03-14 2019-03-14 Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6

Publications (1)

Publication Number Publication Date
ECSP19018367A true ECSP19018367A (es) 2019-06-30

Family

ID=69897284

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI201918367A ECSP19018367A (es) 2019-03-14 2019-03-14 Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6

Country Status (1)

Country Link
EC (1) ECSP19018367A (es)

Similar Documents

Publication Publication Date Title
EA201692192A1 (ru) СВЯЗЫВАЮЩЕЕСЯ С FcRn АНТИТЕЛО ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ ЗАБОЛЕВАНИЙ
CO2021009693A2 (es) Proteínas de unión a antígeno del receptor gamma anti-il2
EA202091569A1 (ru) Моноклональные антитела и способы их применения
MY205967A (en) Monoclonal antibodies against the beta chain region of human trbv9
MY206214A (en) Monoclonal antibodies that bind specifically to human trbv9
EA201890928A1 (ru) Антигенсвязывающие белки, которые активируют лептиновый рецептор
EA201991763A1 (ru) Конъюгаты антитела к ccr7 и лекарственного средства
JOP20210265A1 (ar) الأجسام المضادة لبيروغلوتامات أميلويد بيتا واستخداماتها
EP4276108A3 (en) Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies
ZA202008095B (en) Humanized antibodies against psma
EA202192907A1 (ru) Моноклональное антитело, которое специфически связывается с gitr
BR112022026533A2 (pt) Anticorpo anti-fxi/fxia, fragmento de ligação do mesmo, e antígenos e uso farmacêutico do mesmo
PH12019500342A1 (en) Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6
CO2019002550A2 (es) Anticuerpos anti-gm-csf y usos de los mismos
WO2021222181A3 (en) Isoform-independent antibodies to lipoprotein(a)
MX2022003191A (es) Terapias de combinacion con anticuerpos entpd2 y cd73.
ECSP19018367A (es) Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6
PH12018501674A1 (en) Anti-citrullinated hla polypeptide antibodies and uses thereof